Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)

CUSIP: 71722W107

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
78,837,943
Total 13F shares
55,378,949
Share change
+1,266,073
Total reported value
$588,085,973
Put/Call ratio
180%
Price per share
$10.62
Number of holders
112
Value change
+$14,631,856
Number of buys
50
Number of sells
51

Quarterly Holders Quick Answers

What is CUSIP 71722W107?
CUSIP 71722W107 identifies PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) as of Q1 2024

As of 31 Mar 2024, Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) was held by 112 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,378,949 shares. The largest 10 holders included Frazier Life Sciences Management, L.P., Medicxi Ventures Management (Jersey) Ltd, Carlyle Group Inc., Invesco Ltd., TAKEDA PHARMACEUTICAL CO LTD, BlackRock Inc., Ensign Peak Advisors, Inc, VANGUARD GROUP INC, NEA Management Company, LLC, and Avidity Partners Management LP. This page lists 112 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.